Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: J Diabetes Complications. 2020 Dec 31;35(4):107841. doi: 10.1016/j.jdiacomp.2020.107841

Figure 1. Mechanisms of sexual dimorphism in DKD and potential therapeutic implications.

Figure 1.

Abbreviations: ACEi: Angiotensin-converting enzyme inhibitors; ACE2: Angiotensin-converting enzyme 2; ARB: angiotensin receptor blocker; MAO: Monoamine oxidase; MAOa: Monoamine oxidase type A; PDE5: Phosphodiesterase type 5; RAAS: Renin-angiotensin-aldosterone system; SGLT2: Sodium glucose co-transporter 2.